ES2081900T3 - Composiciones de ensayo de barbituratos y metodos. - Google Patents

Composiciones de ensayo de barbituratos y metodos.

Info

Publication number
ES2081900T3
ES2081900T3 ES90122298T ES90122298T ES2081900T3 ES 2081900 T3 ES2081900 T3 ES 2081900T3 ES 90122298 T ES90122298 T ES 90122298T ES 90122298 T ES90122298 T ES 90122298T ES 2081900 T3 ES2081900 T3 ES 2081900T3
Authority
ES
Spain
Prior art keywords
fluorescent
immunity
analogs
barbiturics
immunogenic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90122298T
Other languages
English (en)
Inventor
Jonathan Grote
Hsiang Hu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott Laboratories
Original Assignee
Abbott Laboratories
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Laboratories filed Critical Abbott Laboratories
Application granted granted Critical
Publication of ES2081900T3 publication Critical patent/ES2081900T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
    • G01N33/948—Sedatives, e.g. cannabinoids, barbiturates
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/536—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
    • G01N33/542—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with steric inhibition or signal modification, e.g. fluorescent quenching
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/80—Fluorescent dyes, e.g. rhodamine
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/815—Test for named compound or class of compounds
    • Y10S436/816—Alkaloids, amphetamines, and barbiturates

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Anesthesiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)

Abstract

LA INVENCION ACTUAL PROPORCIONA LOS METODOS Y LOS COMPUESTOS PARA PROBAR MUESTRAS BIOLOGICAS, TALES COMO SUERO HUMANO, PARA BARBITURICOS. EN UN PRIMER ASPECTO, SE PROPORCIONARAN ANALOGOS DE BARBITURICOS DERIVADOS CON FLUORESCENCIA Y OTROS DERIVADOS CON POLIPETIDOS INMUNOGENICOS. LOS ANALOGOS FLUORESCENTES SE EMPLEAN COMO TRAZADORES EN PRUEBAS DE INMUNIDAD HOMEGENEAS COMPETITIVAS, ASI POR EJ: UNA PRUEBA DE INMUNIDAD A LA POLARIZACION FLUORESCENTE, PARA DETECCION DE BARBITURICOS. LOS ANALOGOS INMUNOGENICOS SE EMPLEAN PARA HACER ANTISUEROS ANTIBARBITURICOS DE LA INVENCION A UTILIZAR EN EL METODO DE PRUEBAS DE INMUNIDAD. TAMBIEN SE PROPORCIONAN INTERMEDIARIOS PARA PREPARAR LOS ANALOGOS FLUORESCENTES E INMUNOGENICOS. ADEMAS, SE PROPORCIONAN KITS DE PRUEBAS, QUE COMPRENDEN UN TRAZADOR FLUORESCENTE Y UN ANTISUERO DE ACUERDO CON LA INVENCION, PARA ANALIZAR MUESTRAS BIOLOGICAS MEDIANTE PRUEBAS DE INMUNIDAD DE POLARIZACION FLUORESCENTE PARA LA PRESENCIA DE UN BARBITURICO. TAMBIEN SE PROPORCIONA UN PERFECCIONAMIENTO DE LAS PRUEBAS DE INMUNIDAD PARA LAS ANALITICAS DE LOS SUEROS, DONDE UNOS MEDIOS DE TRANSFERENCIA, TALES COMO UNA PIPETA, SE UTILIZARAN REPETIDAMENTE PARA TRANSFERIR DISTINTAS MUESTRAS AL SISTEMA DE PRUEBAS. EN EL PERFECCIONAMIENTO SE UTILIZARA UNA SOLUCION ACUOSA DE UN COMPUESTO ESPECIFICO, QUE COMPRENDE DIMETILSULFOXIDO Y UN ALCALI HALOIDEO, PARA LIMPIAR LOS MEDIOS DE TRANSFERENCIA ENTRE DICHAS TRANSFERENCIAS.
ES90122298T 1989-11-27 1990-11-22 Composiciones de ensayo de barbituratos y metodos. Expired - Lifetime ES2081900T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/441,956 US5096838A (en) 1989-11-27 1989-11-27 Barbiturate assay compositions and methods

Publications (1)

Publication Number Publication Date
ES2081900T3 true ES2081900T3 (es) 1996-03-16

Family

ID=23754973

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90122298T Expired - Lifetime ES2081900T3 (es) 1989-11-27 1990-11-22 Composiciones de ensayo de barbituratos y metodos.

Country Status (6)

Country Link
US (1) US5096838A (es)
EP (1) EP0430065B1 (es)
JP (1) JP3065097B2 (es)
CA (1) CA2030689C (es)
DE (1) DE69023615T2 (es)
ES (1) ES2081900T3 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69232002T2 (de) * 1991-06-07 2002-06-06 Johnson & Johnson Clinical Diagnostics, Inc. Immunoassays unter Verwendung von markierten Hapten-Analogen
US5326708A (en) * 1992-02-28 1994-07-05 Lewis Douglas E Forensically acceptable determinations of gestational fetal exposure to drugs and other chemical agents
ATE362380T1 (de) * 1995-03-31 2007-06-15 Xenova Res Ltd Hapten-träger-konjugate zur anwendung in der drogen-missbrauchs-therapie
US5773003A (en) * 1995-03-31 1998-06-30 Immulogic, Inc. Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of same
ATE492565T1 (de) * 2002-01-31 2011-01-15 Randox Lab Ltd Immunogene, antikörper und konjugate für ketamin und dessen metaboliten
US8133743B2 (en) * 2007-10-19 2012-03-13 Roche Diagnostics Operations, Inc. Phenobarbital derivatives useful in immunoassay

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3923995A (en) * 1968-08-05 1975-12-02 Kendall & Co Anticonvulsant compositions containing diphenylhydantoin compounds and method of using same
US4107157A (en) * 1973-07-12 1978-08-15 Hoffmann-La Roche Inc. Barbituric acid antigens and antibodies specific therefor
US4588697A (en) * 1979-09-07 1986-05-13 Syntex (U.S.A.) Inc. Method for performing fluorescent protein binding assay employing novel alkyl substituted fluorescent compounds and conjugates
AU555213B2 (en) * 1981-02-17 1986-09-18 Abbott Laboratories N-substituted-amido-fluoresein derivatives
US4585862A (en) * 1981-12-11 1986-04-29 Abbott Laboratories Fluorescence polarization immunoassay
US4614823A (en) * 1982-11-08 1986-09-30 Abbott Laboratories Aminomethylfluorescein derivatives
US4476229A (en) * 1982-11-08 1984-10-09 Abbott Laboratories Substituted carboxyfluoresceins

Also Published As

Publication number Publication date
JP3065097B2 (ja) 2000-07-12
EP0430065A2 (en) 1991-06-05
DE69023615D1 (de) 1995-12-21
JPH03190877A (ja) 1991-08-20
DE69023615T2 (de) 1996-06-13
CA2030689C (en) 2002-12-03
EP0430065B1 (en) 1995-11-15
US5096838A (en) 1992-03-17
EP0430065A3 (en) 1993-03-17
CA2030689A1 (en) 1991-05-28

Similar Documents

Publication Publication Date Title
ES2052610T3 (es) Un metodo de determinacion de anfetamina y/o metanfetamina en una muestra de ensayo.
ES541870A0 (es) Un procedimiento para preparar un dispositivo de ensayo para determinar la presencia de leucocitos, esterasa o proteasa en una muestra.
ES2141170T3 (es) Procedimiento mejorado de deteccion de celulas diana especificas en una poblacion de celulas especializadas o mixtas y soluciones que contienen una poblacion de celulas mixtas.
FI915150A7 (fi) Menetelmät, reagenssit ja testikäyttöpakkaukset biologisten yksiköiden alapopulaatioiden määrittämiseksi
ES8608169A1 (es) Un metodo de detectar en una muestra un analito
ES2062994T3 (es) Procedimiento para la determinacion de anticuerpos.
DE3575789D1 (de) Gleichseitige mehrfache proben und in denselben zu verwendende zusammensetzungen.
BR8900409A (pt) Processo para a deteccao da presenca de um composto marcador,estojo de ensaio,solucao com anticorpos monoclonais e composto a base de oleo
DE3685937D1 (de) Testverfahren mit oberflaechengebundenem fibrinogen und loesliches markiertes fibrinogen.
ES2009907A6 (es) Procedimiento para detectar en sangre humana la presencia de anticuerpos frente al virus sida.
BR8507089A (pt) Aparelho para coleta e/ou desenvolvimento de culturas biologicas protegidas
BR9915406A (pt) Dispositivo e método para a análise de uma amostra biológica
ES2194116T3 (es) Procedimiento para detectar anticuerpos antipolimero y kit de prueba de diagnostico para uso como ayuda al diagnostico de las enfermedades relacionadas con silicona.
ES512498A0 (es) "metodo y su correspondiente aparato para el ensayo de anticuerpos con respecto a antigenos solubles".
SE7704305L (sv) Forfarande for analys av ett biologiskt vetskeprov
ES522432A0 (es) Perfeccionamientos en un dispositivo de analisis para determinar la presencia de actividad esterada en una muestra de liquido.
ES2196073T3 (es) Prueba inmunologica de agentes farmacologicos facilitada con detergente.
ES2081900T3 (es) Composiciones de ensayo de barbituratos y metodos.
ES2095858T3 (es) Sustratos de beta-galactosidasa.
ES2056154T3 (es) Procedimiento para la determinacion de una sustancia capaz de fijarse especificamente.
ES2070488T5 (es) Procedimiento para la diagnosis de enfermedades tumorales.
ES2065982T3 (es) Metodo y equipo utilizado en ensayos de hombres en cuanto a fertilidad.
ATE132974T1 (de) Test, indikatoren, immunogene und antikörper für benzodiazepine
ES8609723A1 (es) Procedimiento para la valoracion inmunologica de una subs- tancia, especialmente un antigeno un hapteno o un anticuerpo
ES2159291T3 (es) Metodo y analisis de htlv-i/htlv-ii.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 430065

Country of ref document: ES